Inventiva S.A. (IVA.PA)
EUR 3.24
(2.37%)
EUR 3.24
(2.37%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.43 EUR | -85.5% |
| 2022 | -1.31 EUR | -3.15% |
| 2021 | -1.27 EUR | -36.56% |
| 2020 | -0.93 EUR | 27.34% |
| 2019 | -1.28 EUR | 21.95% |
| 2018 | -1.64 EUR | -47.75% |
| 2017 | -1.11 EUR | -146.67% |
| 2016 | -0.45 EUR | 48.86% |
| 2015 | -0.88 EUR | -17.33% |
| 2014 | -0.75 EUR | -5.63% |
| 2013 | -0.71 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.94 EUR | 0.0% |
| 2023 Q2 | -1.31 EUR | 0.0% |
| 2023 FY | - EUR | -85.5% |
| 2023 Q4 | -1.13 EUR | 0.0% |
| 2022 Q4 | -0.59 EUR | 0.0% |
| 2022 Q2 | -0.72 EUR | 0.0% |
| 2022 FY | - EUR | -3.15% |
| 2021 Q2 | -0.37 EUR | -60.87% |
| 2021 Q1 | -0.23 EUR | 51.06% |
| 2021 FY | - EUR | -36.56% |
| 2021 Q4 | -0.67 EUR | 0.0% |
| 2020 FY | - EUR | 27.34% |
| 2020 Q1 | -0.23 EUR | 36.11% |
| 2020 Q2 | -0.23 EUR | 0.0% |
| 2020 Q4 | -0.47 EUR | 0.0% |
| 2019 FY | - EUR | 21.95% |
| 2019 Q4 | -0.36 EUR | 0.0% |
| 2019 Q2 | -0.93 EUR | -190.63% |
| 2019 Q1 | -0.32 EUR | 57.89% |
| 2018 Q4 | -0.76 EUR | 0.0% |
| 2018 FY | - EUR | -47.75% |
| 2018 Q2 | -0.86 EUR | -109.76% |
| 2018 Q1 | -0.41 EUR | 28.07% |
| 2017 FY | - EUR | -146.67% |
| 2017 Q1 | -0.28 EUR | 6.67% |
| 2017 Q2 | -0.67 EUR | -139.29% |
| 2017 Q4 | -0.57 EUR | 0.0% |
| 2016 Q4 | -0.30 EUR | 0.0% |
| 2016 Q2 | -0.41 EUR | -127.78% |
| 2016 Q1 | -0.18 EUR | 57.14% |
| 2016 FY | - EUR | 48.86% |
| 2015 FY | - EUR | -17.33% |
| 2015 Q4 | -0.42 EUR | -90.91% |
| 2015 Q3 | -0.22 EUR | 52.17% |
| 2015 Q2 | -0.46 EUR | -109.09% |
| 2015 Q1 | -0.22 EUR | 0.0% |
| 2014 FY | - EUR | -5.63% |
| 2014 Q2 | -0.19 EUR | 0.0% |
| 2014 Q1 | -0.19 EUR | 0.0% |
| 2014 Q3 | -0.19 EUR | 0.0% |
| 2014 Q4 | -0.22 EUR | -15.79% |
| 2013 Q3 | -0.18 EUR | 0.0% |
| 2013 Q1 | -0.18 EUR | 0.0% |
| 2013 Q4 | -0.19 EUR | -5.56% |
| 2013 FY | - EUR | 0.0% |
| 2013 Q2 | -0.18 EUR | 0.0% |
| 2012 Q4 | -0.18 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -1925.0% |
| ABIVAX Société Anonyme | -3.43 EUR | 29.155% |
| Adocia SA | -1.91 EUR | -27.225% |
| Aelis Farma SA | -0.39 EUR | -523.077% |
| Biophytis S.A. | -12.55 EUR | 80.637% |
| Advicenne S.A. | -0.67 EUR | -262.687% |
| genOway Société anonyme | 0.17 EUR | 1529.412% |
| IntegraGen SA | -0.03 EUR | -9282.239% |
| Medesis Pharma S.A. | -0.80 EUR | -203.75% |
| Neovacs S.A. | -0.00 EUR | -97100.0% |
| NFL Biosciences SA | -0.46 EUR | -428.261% |
| Plant Advanced Technologies SA | 0.07 EUR | 3571.429% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -2570.33% |
| Sensorion SA | -0.17 EUR | -1329.412% |
| Theranexus Société Anonyme | -0.88 EUR | -176.136% |
| TME Pharma N.V. | -1.34 EUR | -81.343% |
| Valbiotis SA | -0.59 EUR | -311.864% |
| TheraVet SA | -0.49 EUR | -395.918% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -1520.0% |
| DBV Technologies S.A. | -0.71 EUR | -242.254% |
| Genfit S.A. | -0.58 EUR | -318.966% |
| GeNeuro SA | -0.59 EUR | -311.864% |
| Innate Pharma S.A. | -0.09 EUR | -2482.359% |
| MaaT Pharma SA | -1.73 EUR | -40.462% |
| MedinCell S.A. | -0.88 EUR | -176.136% |
| Nanobiotix S.A. | -1.08 EUR | -125.0% |
| OSE Immunotherapeutics SA | -1.18 EUR | -105.932% |
| Poxel S.A. | -0.91 EUR | -167.033% |
| GenSight Biologics S.A. | -0.54 EUR | -350.0% |
| Transgene SA | -0.22 EUR | -1004.545% |
| Valneva SE | -0.73 EUR | -232.877% |